Cabaletta Bio (CABA) Retained Earnings (2018 - 2025)
Cabaletta Bio (CABA) recorded quarterly Retained Earnings of -$517.0 million in Q4 2025, down 2247739.13% quarter-over-quarter from $23000.0 in Q3 2025, and down 48.08% on a YoY basis from -$995.7 million in Q4 2024.
Cabaletta Bio (CABA) Retained Earnings (2018 - 2025) Analysis & Trends
Cabaletta Bio's Retained Earnings history runs 8 years deep, the most recent figure standing at -$517.0 million for Q4 2025.
- In Q4 2025, Retained Earnings fell 48.08% year-over-year to -$517.0 million; the TTM figure through Dec 2025 stood at -$517.0 million (down 48.08% YoY), while the FY2025 annual figure was -$517.0 million, down 48.08% from the prior year.
- Retained Earnings was -$517.0 million for Q4 2025 at Cabaletta Bio, down from $23000.0 in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $39000.0 in Q4 2023 to a low of -$517.0 million in Q4 2025.
- Historically, Retained Earnings has averaged -$121.7 million across 5 years, with a median of -$38.1 million in 2021.
- The sharpest annual moves came in 2021 and 2025: Retained Earnings tumbled 1876550.0% in 2021, then jumped 2200.0% in 2025.
- A 5-year view of Retained Earnings shows it stood at -$112.6 million in 2021, then jumped by 99.96% to -$47000.0 in 2022, then jumped by 182.98% to $39000.0 in 2023, then plunged by 895230.77% to -$349.1 million in 2024, then sank by 48.08% to -$517.0 million in 2025.
- The last three Retained Earnings figures came in at -$517.0 million (Q4 2025), $23000.0 (Q3 2025), and -$430.2 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Cabaletta Bio | 151.84 Mn | 18.24 Mn | - | -516.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -516.96 Mn |
| Sep 30, 2025 | 23,000.00 |
| Jun 30, 2025 | -430.17 Mn |
| Mar 31, 2025 | -385.04 Mn |
| Dec 31, 2024 | -349.10 Mn |
| Sep 30, 2024 | 1,000.00 |
| Jun 30, 2024 | -29,000.00 |
| Mar 31, 2024 | -38,000.00 |
| Dec 31, 2023 | 39,000.00 |
| Sep 30, 2023 | -21,000.00 |
| Jun 30, 2023 | -195.90 Mn |
| Mar 31, 2023 | -181.42 Mn |
| Dec 31, 2022 | -47,000.00 |
| Sep 30, 2022 | -209,000.00 |
| Jun 30, 2022 | -249,000.00 |
| Mar 31, 2022 | -152,000.00 |
| Dec 31, 2021 | -112.59 Mn |
| Sep 30, 2021 | -98.70 Mn |
| Jun 30, 2021 | -87.14 Mn |
| Mar 31, 2021 | -76.00 Mn |